NF-kappa B and HIV: linking viral and immune activation
- PMID: 10987091
- DOI: 10.1016/s1054-3589(00)48006-3
NF-kappa B and HIV: linking viral and immune activation
Similar articles
-
Modulation of HIV-enhancer activity by heterologous agents: a minireview.Gene. 1991 May 30;101(2):165-70. doi: 10.1016/0378-1119(91)90407-3. Gene. 1991. PMID: 2055485 Review.
-
HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes.Nature. 1991 Apr 25;350(6320):709-12. doi: 10.1038/350709a0. Nature. 1991. PMID: 2023633
-
Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.J Immunol. 1990 Dec 15;145(12):4348-54. J Immunol. 1990. PMID: 2258623
-
Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.J Immunol. 1998 Jul 1;161(1):268-76. J Immunol. 1998. PMID: 9647233
-
[Recent progress in the study of HIV-1 transcription factor NF-kappaB and its inhibitors].Yao Xue Xue Bao. 2007 Oct;42(10):1007-12. Yao Xue Xue Bao. 2007. PMID: 18229603 Review. Chinese.
Cited by
-
Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.J Virol. 2002 Nov;76(21):11091-103. doi: 10.1128/jvi.76.21.11091-11103.2002. J Virol. 2002. PMID: 12368351 Free PMC article.
-
HIV-1 Nef inhibits lipopolysaccharide-induced IL-12p40 expression by inhibiting JNK-activated NFkappaB in human monocytic cells.J Biol Chem. 2009 Mar 20;284(12):7578-87. doi: 10.1074/jbc.M710013200. Epub 2008 Nov 19. J Biol Chem. 2009. Retraction in: J Biol Chem. 2012 Jan 2;287(1):804. doi: 10.1074/jbc.A111.710013 PMID: 19019824 Free PMC article. Retracted.
-
Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env.J Virol. 2006 Sep;80(17):8729-38. doi: 10.1128/JVI.00558-06. J Virol. 2006. PMID: 16912320 Free PMC article.
-
Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways.Molecules. 2017 Feb 19;22(2):321. doi: 10.3390/molecules22020321. Molecules. 2017. PMID: 28218730 Free PMC article.
-
Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4+ T Cells.J Virol. 2019 Nov 26;93(24):e00969-19. doi: 10.1128/JVI.00969-19. Print 2019 Dec 15. J Virol. 2019. PMID: 31578289 Free PMC article.